133 related articles for article (PubMed ID: 9152613)
1. Glutamic acid decarboxylase65 (GAD65) antibodies and insulin auto-antibodies in Japanese patients with non-insulin-dependent diabetes mellitus.
Maruyama T; Kasuga A; Ozawa Y; Nagata A; Abiko F; Suzuki Y; Saruta T
Endocr J; 1997 Feb; 44(1):43-51. PubMed ID: 9152613
[TBL] [Abstract][Full Text] [Related]
2. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults.
Zhou Z; Ouyang L; Peng J; Yang W; Wang J; Zhu X; Wu H; Dyrberg T
Chin Med J (Engl); 1999 Jun; 112(6):554-7. PubMed ID: 11601338
[TBL] [Abstract][Full Text] [Related]
4. [Glutamic acid decarboxylase autoantibodies (antiGAD-Ab) in patients with non-insulin dependent diabetes mellitus (NIDDM)].
Martinka E; Straková J; Ocenásová A; Pullmannová D; Petrisková J; Mácková N; Sutarík L; Galajda P; Baláz D; Kerný J; Vladár L; Mokán M
Vnitr Lek; 1998 Jan; 44(1):17-22. PubMed ID: 9750478
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
[TBL] [Abstract][Full Text] [Related]
7. Antibody to the M(r) 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese.
Kasuga A; Maruyama T; Ozawa Y; Takei I; Falorni A; Lernmark A; Saruta T
J Autoimmun; 1996 Feb; 9(1):105-11. PubMed ID: 8845047
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
[TBL] [Abstract][Full Text] [Related]
10. [Autoantibodies to GAD65, IA2 and insulin in Czech children with type 1 diabetes].
Cinek O; Pechová M; Kolousková S; Horká I; Sedláková P; Sumník Z; Snajderová M; Vavrinec J
Cas Lek Cesk; 2000 Sep; 139(19):599-603. PubMed ID: 11192752
[TBL] [Abstract][Full Text] [Related]
11. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry.
Vandewalle CL; Falorni A; Svanholm S; Lernmark A; Pipeleers DG; Gorus FK
J Clin Endocrinol Metab; 1995 Mar; 80(3):846-51. PubMed ID: 7883841
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to GAD in Japanese patients classified as Type 2 diabetes at diagnosis. High titre of GAD Ab is a predictive marker for early insulin treatment--report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD Ab(+) diabetes.
Takino H; Yamasaki H; Abiru N; Sera Y; Abe T; Kawasaki E; Yamaguchi Y; Eguchi K; Kanazawa Y; Nagataki S
Diabet Med; 2002 Sep; 19(9):730-4. PubMed ID: 12207808
[TBL] [Abstract][Full Text] [Related]
15. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in children with type 2 diabetes mellitus.
Umpaichitra V; Banerji MA; Castells S
J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():525-30. PubMed ID: 12017227
[TBL] [Abstract][Full Text] [Related]
17. Role of beta-cell autoantibodies as a predictor marker in diabetic patients and their relationship to glycemic control.
Ali NA; Swelam E; AI Banna EA; Showkry A
Egypt J Immunol; 2012; 19(1):39-49. PubMed ID: 23888550
[TBL] [Abstract][Full Text] [Related]
18. Glutamic acid decarboxylase antibodies in non-insulin-dependent diabetes patients with secondary sulfonylurea failure in Thailand.
Rattarasarn C; Aguilar Diosdado M; Soonthornpun S
Diabetes Res Clin Pract; 1997 Sep; 37(3):193-7. PubMed ID: 9306041
[TBL] [Abstract][Full Text] [Related]
19. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to glutamic acid decarboxylase (GAD) in non-obese Japanese diabetics without insulin therapy: a comparison of two commercial RIA kits based on recombinant and pig brain GAD.
Bando Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M
Diabetes Res Clin Pract; 1998 Jul; 41(1):25-33. PubMed ID: 9768369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
